AACR - In Memoriam: Judah Folkman, M.D. (1933-2008)

午觉刚睡醒，秘书转来了老板的邮件，居然是这个噩耗。

去年的这个时候，我在看他的传记。2001年时，美国新闻日报（Newsday）的记者Robert Cooke为他写的传记，当时苦于找不到原版，但是上海人民出版社把他翻译过来了，中文书名叫《佛克曼：无痛治癌不是梦》，找遍当了网上书城和淘宝都没有找到这本书，只好看了一下超星的电子书，因为超星的很多麻烦，我把它转成了pdf格式做收藏。感兴趣的朋友可以向我索取。

他是我不多的记得全名的外国人之一，也是我读过的唯一一本传记的主人公。

如下是他的paper的一些数据：

总数: 524

被引次数: 74,918

平均每文被引次数: 142.97

h 指数: 122 (122 papers that have been cited 122 times or more)

Folkman J @ ISI数据

http://www.dxy.cn/bbs//user/download/10954950/Judah%20Folkman.pdf

《佛克曼：无痛治癌不是梦》一书pdf版的下载地址：

http://ishare.sina.com.cn/cgi-bin/fileid.cgi?fileid=3081558

http://www.aacr.org/home/about-us/news.aspx?d=955

---

In Memoriam: Judah Folkman, M.D. (1933-2008)

January 15, 2008

PHILADELPHIA -- Judah Folkman, M.D., director of the vascular biology program at Children's Hospital Boston and the Andrus professor of pediatric surgery and professor of cell biology at Harvard Medical School, died suddenly January 14, 2008. He was 74.

Internationally renowned as a pioneer in the field of angiogenesis research, Dr. Folkman's landmark discovery that cutting off a cancerous tumor's blood supply inhibited its growth and ability to spread revolutionized cancer treatment. Dr. Folkman's laboratory was the first to purify angiogenic protein from a tumor, basic research which led to the discovery of the first angiogenesis inhibitors and ultimately to clinical trials of anti-angiogenic therapy. Today, angiogenesis inhibitors such as Avastin, Tarceva and Macugen have received FDA approval in the U.S. and similar regulatory approval in 27 other countries for the treatment of cancer and/or macular degeneration. Dr. Folkman's research provides a firm scientific foundation for the pursuit of anti-angiogenic therapy, not only for the treatment of cancer, but for many non-neoplastic diseases.

"Judah Folkman's passing is a tremendous and tragic loss for humankind," said AACR Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.). "In addition to his brilliant and distinguished cancer research career, Judah was highly regarded by the cancer community as a supportive mentor, a dedicated teacher, and esteemed colleague. His legacy of discovery and ingenuity in the field of angiogenesis will continue to inspire cancer researchers and give hope to countless individuals living with the disease. He was certainly a valued friend of the AACR and we extend our deepest condolences to the Folkman family."

An active member of the American Association for Cancer Research since 1990, Dr. Folkman served as an associate editor of two AACR journals, Cancer Research (1990 - 2000) and Clinical Cancer Research (1999 - 2002). He was the 1985 recipient of the AACR- G.H.A. Clowes Memorial Award in recognition of his outstanding accomplishments in cancer research. Dr. Folkman also demonstrated his commitment to cancer research philanthropy as a trustee of the AACR Foundation for the Prevention and Cure of Cancer.

Through his work with the AACR and through leadership and advisory positions with a host of prestigious scientific institutions and organizations such as the National Institutes of Health, The National Academy of Sciences, the Institute of Medicine and the American Pediatric Surgical Association, Dr. Folkman helped to define the field of cancer and biomedical research.